Linganisha mbinu

	Kikokotoo cha Utambuzi wa Tatizo la Matumizi ya Bangi	Brief Addiction Monitor (BAM)	Kipimo cha DUDIT (Drug Use Disorders Identification Test)
Nyanja	Tiba ya Uraibu	Tiba ya Uraibu	Tiba ya Uraibu
Familia	Process / pipeline	Process / pipeline	Process / pipeline
Mwaka wa asili	2010	2013	2005
Mwanzilishi	Adamson, Kay-Lambkin, Baker, Lewin, Thornton, Kelly, Sellman	Cacciola, Alterman, Drapkin, Valadez	Berman, Bergman, Palmstierna, Schlyter
Aina	Self-report	Self-report	Self-report
Chanzo asilia	Adamson, S. J., Kay-Lambkin, F. J., Baker, A. L., Lewin, T. J., Thornton, L., Kelly, B. J., & Sellman, J. D. (2010). An improved brief screening instrument for cannabis use disorder. Drug and Alcohol Dependence, 110(1–2), 55–60.	Cacciola, J. S., Alterman, A. I., Drapkin, M. L., & Valadez, C. (2013). Development and initial validation of the Brief Addiction Monitor (BAM). Journal of Substance Abuse Treatment, 44(3), 256–263.	Berman, A. H., Bergman, H., Palmstierna, T., & Schlyter, F. (2005). Evaluation of the Drug Use Disorder Identification Test (DUDIT) in criminal justice and detoxification settings and in a Swedish population sample. European Addiction Research, 11(1), 22–31.
Majina mbadala	CUDIT-R, CUDIT	BAM	DUDIT
Zinazohusiana	4	4	4
Muhtasari	The CUDIT-R is a brief, 8-item self-report screening instrument developed to identify cannabis use disorder and hazardous cannabis use patterns. Introduced by Adamson and colleagues in 2010 as a revision of the original CUDIT, the CUDIT-R improves brevity and screening efficiency while maintaining strong psychometric properties. It is designed for use in primary care, addiction treatment, and public health settings to detect problematic cannabis use and inform treatment allocation decisions.	The BAM is a 17-item self-report instrument designed to provide rapid, multimodal assessment of substance use, craving, risk factors, protective factors, and psychosocial functioning in individuals receiving addiction treatment. Developed by Cacciola and colleagues in 2013, it serves as an efficient outcome monitoring tool for tracking treatment progress, identifying relapse warning signs, and guiding therapeutic adjustments. The BAM is useful in treatment settings where frequent assessment of multiple domains is needed to optimize care.	The DUDIT is a brief, gender-sensitive screening instrument designed to identify individuals with harmful or hazardous drug use patterns across a wide range of substances. Developed by Berman and colleagues in 2005, it serves as a primary care and public health screening tool to detect drug-related problems before they escalate to dependence or disorder. The DUDIT is freely available and has been validated in multiple languages and settings.